Aetiopathogenesis, molecular determinants and immunological features

Paolo Spagnolo, Johan Grunewald

Source: Eur Respir Monogr 2022; 96: 25-40
Journal Issue: Sarcoidosis

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paolo Spagnolo, Johan Grunewald. Aetiopathogenesis, molecular determinants and immunological features. Eur Respir Monogr 2022; 96: 25-40

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pathogenesis, molecular and cellular features
Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management
Year: 2006

To the molecular genetic mechanisms of the COPD pathogenesis
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Clinical relevance of COPD muscle dysfunction and body composition alterations, and their risk factors and underlying mechanisms
Source: International Congress 2016 – PG15 Muscle weakness and wasting in chronic obstructive pulmonary disease
Year: 2016



Unravelling the genetic basis of sarcoidosis
Source: Eur Respir Monogr 2022; 96: 41-56
Year: 2022


Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Source: Eur Respir J 2009; 33: 1485-1497
Year: 2009



Molecular and genetic mechanisms in gender issues
Source: Virtual Congress 2021 – Highlights on gender and respiratory health
Year: 2021


New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms
Source: Eur Respir J 2007; 29: 793-803
Year: 2007



Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy
Source: Eur Respir J, 59 (2) 2102245; 10.1183/13993003.02245-2021
Year: 2022



Advances in knowledge of global epidemiology, pathogenesis and risk factors
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008


Early determinants of airway function: epidemiological and physiological evidence
Source: ISSN=ISSN 1810-6838, ISBN=, page=147
Year: 2007

COPA syndrome restricted to life-threatening alveolar hemorrhages: clinical, pathological, molecular and biological characterization
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018



To progress understanding of disease triggers and modifiers in sarcoidosis, stratification is the key
Source: Eur Respir J, 50 (6) 1702002; 10.1183/13993003.02002-2017
Year: 2017



COVID-19 and obesity: specific clinical and laboratory features
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021


Many-faced histological patterns of hypersensitivity pneumonia: the insights to diagnostics
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020